Publikasi Scopus 2024 per tanggal 30 Juni 2024 (499 artikel)

Kurniawan J.; Teressa M.
Kurniawan, Juferdy (57193251655); Teressa, Maria (57957998500)
57193251655; 57957998500
Insulin Use and The Risk of Hepatocellular Carcinoma: Insights and Implications
2024
Acta Medica Indonesiana
56
1
107
113
6
0
Division of Hepatobiliary, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia – Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia
Kurniawan J., Division of Hepatobiliary, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia – Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Teressa M., Division of Hepatobiliary, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia – Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia
In recent years, the incidence of diabetes mellitus and hepatocellular carcinoma (HCC) has been increasing worldwide, in the context of an increasing prevalence of non-alcoholic fatty liver disease (NAFLD). In patients with diabetes mellitus, exogenous insulin is commonly prescribed and used in long-term settings. Recent studies suggest that insulin use may elevate the risk of HCC. A substantial body of work seeks to unpack the association between insulin use and the risk of developing HCC, although there may be conflicting evidence. Further validation is necessary to clarify the true relationship between insulin mechanisms and its hepatocarcinogenic effect. Given the burden of diabetic patients developing HCC, diabetologists and hepatologists must collaborate, particularly regarding the prevention and surveillance of HCC in diabetic patients. © 2024, Indonesian Society of Internal Medicine. All rights reserved.
hepatocellular carcinoma; insulin; insulin use; risk
Carcinoma, Hepatocellular; Diabetes Mellitus; Humans; Insulin; Liver Neoplasms; Non-alcoholic Fatty Liver Disease; Risk Factors; insulin; complication; diabetes mellitus; human; liver cell carcinoma; liver tumor; nonalcoholic fatty liver; pathology; risk factor
Indonesian Society of Internal Medicine
01259326
38561879
Review
Q3
282
15714